The trafficking of normal cellular prion protein (PrPC) is believed to control its conversion to the altered conformation (designated PrPSc) associated with prion disease. Although anchored to the membrane by means of glycosylphosphatidylinositol (GPI), PrPC on neurons is rapidly and constitutively endocytosed by means of coated pits, a property dependent upon basic amino acids at its N-terminus. Here, we show that low-density lipoprotein receptor-related protein 1 (LRP1), which binds to multiple ligands through basic motifs, associates with PrPC during its endocytosis and is functionally required for this process. Moreover, sustained inhibition of LRP1 levels by siRNA leads to the accumulation of PrPC in biosynthetic compartments, with a concomitant lowering of surface PrPC, suggesting that LRP1 expedites the trafficking of PrPC to the neuronal surface. PrPC and LRP1 can be co-immunoprecipitated from the endoplasmic reticulum in normal neurons. The N-terminal domain of PrPC binds to purified human LRP1 with nanomolar affinity, even in the presence of 1 μM of the LRP-specific chaperone, receptor-associated protein (RAP). Taken together, these data argue that LRP1 controls both the surface, and biosynthetic, trafficking of PrPC in neurons.

PrPC is endocytosed by mechanisms that differ according to the cell type studied, presumably reflecting differences in the expression of partner proteins that determine the trafficking of PrPC that lacks a cytoplasmic domain into which endocytic trafficking motifs could be embedded. On N2a cells, PrPC is endocytosed constitutively by means of coated pits (Shyng et al., 1994; Sunyach et al., 2003); whereas cells that do not endogenously express PrPC but transfected with a vector encoding PrPC can require 100 μM Cu2+ to initiate coated pit endocytosis (Taylor and Hooper, 2007) or else slowly internalise PrPC by non-coated pit mechanisms (Peters et al., 2003).

The cell type of prime relevance to mammalian prion biology is the neuron. PrPC occupies lipid rafts that, on neurons, are distinctive, differing both chemically and spatially from those containing the major neuronal glycosylphosphatidylinositol (GPI)-anchored protein, Thy-1 (Brügger et al., 2004; Madore et al., 1999; Sunyach et al., 2003). PrPC exits its rafts to traverse detergent-soluble membrane as it enters coated pits for endocytosis and then recycles back to the surface via perinuclear sorting compartments, the entire cycle taking 6-10 minutes (Morris et al., 2006; Sunyach et al., 2003).

PrPC has two distinct domains (Fig. 1): a GPI-anchored, α-helical C-terminal domain (amino acids 126-231) and an unstructured N-terminal domain (residues 23-125) that is necessary and sufficient for coated pit endocytosis (Shyng et al., 1995a; Sunyach et al., 2003), with the immediate N-terminal basic motif (NH2-KKRPKP-) being essential for this process (Sunyach et al., 2003).

Binding through a basic motif to low-density lipoprotein receptor-related protein 1 (LRP1) is the mechanism by which the GPI-anchored urokinase plasminogen activator receptor is internalised by means of coated pits (Horn et al., 1998). This prompted us to investigate whether LRP1 is the endocytic partner for neuronal PrPC (Morris et al., 2006). Recently, Taylor and Hooper (Taylor and Hooper, 2007) reported that LRP1 is required for the Cu2+-dependent endocytosis of exogenous PrPC on SH-SY5Y cells.

LRP1 is a massive protein (∼600 kDa) that is proteolytically nicked during biosynthesis to give two stably associated polypeptides: an 85-kDa membrane-spanning C-terminal fragment and a 515-kDa extracellular N-terminal chain (Fig. 1). LRP1 is expressed abundantly on neurons (Bu et al., 1994; Moestrup et al., 1992), where its fundamental role is the uptake of cholesterol and fatty acids by these cells whose vast membrane processes require the import of glial-derived sterol and lipid for growth and synapse formation (Mauch et al., 2001). In addition, LRP1 binds to >30 ligands extracellularly, and its cytoplasmic domain binds to endocytic and scaffold adaptors that link the receptor to other membrane proteins, including Alzheimer's precursor protein (APP) (Herz and Chen, 2006; Zerbinatti et al., 2004). The LRP1 knockout mouse is embryonic lethal, and even a partial knockout in adult brain results in slow lethality (May et al., 2004).

LRP family members have a specific chaperone, receptor-associated protein (RAP), that masks their ligand-binding sites during biosynthesis. Recombinant RAP added externally to cells inhibits the binding and endocytosis of LRP ligands (Iadonato et al., 1993; Moestrup et al., 1993b).

Fig. 1.

Schematic view of the domain structure of LRP1 [adapted from Li et al. (Li et al., 2000) and Springer (Springer, 1998)] and PrPC, for which the flexible N- and structured C-terminal domains, and GPI anchor, are indicated; grey lines represent the surface membrane. LRP1 domains and the site of furin cleavage are indicated; Roman numerals indicate the four repeats of the ligand-binding complement-like domains; endocytic motifs are indicated in the cytoplasmic domain. LRP1, with >4500 amino acids, is more than 20 times larger than PrPC (208 amino acids).

Fig. 1.

Schematic view of the domain structure of LRP1 [adapted from Li et al. (Li et al., 2000) and Springer (Springer, 1998)] and PrPC, for which the flexible N- and structured C-terminal domains, and GPI anchor, are indicated; grey lines represent the surface membrane. LRP1 domains and the site of furin cleavage are indicated; Roman numerals indicate the four repeats of the ligand-binding complement-like domains; endocytic motifs are indicated in the cytoplasmic domain. LRP1, with >4500 amino acids, is more than 20 times larger than PrPC (208 amino acids).

PrPC has also been ascribed numerous binding partners (Linden et al., 2007). Any attempt to add to its list of molecular associates needs to demonstrate both specificity and biological relevance. One reported receptor for PrP is the laminin precursor protein (confusingly also abbreviated `LRP') (Gauczynski et al., 2001) that functions both as a cytoplasmic ribosomal subunit and a broad-specificity adhesive protein on the cell surface (Kazmin et al., 2003).

We report here that LRP1 associates with endogenously expressed PrPC on the neuronal cell surface to internalise it and, furthermore, that LRP1 binds to PrPC in biosynthetic compartments to assist its trafficking to the neuronal surface.

Colocalisation of LRP1 and PrPC on the cell surface

Sensory neurons are in this study used because in vivo they uniquely have axons and no dendrites; thus, lacking any synaptic input, they are not denervated upon being dissociated and so survive, remain differentiated and regenerate their axons when introduced into culture from adult tissue (Scott, 1977). In dissociated culture, they extend axons over laminin-coated substrates and flattened satellite cells, while their large cell bodies float, usually without contacting other cells, into the medium above. Fig. 2A,B shows immunolabelling for PrPC at the level of the substrate, and the zone 6 μm above this, where the large neuronal cell bodies are suitable for analysis of the endocytic trafficking of fluorescently labelled surface proteins.

Fig. 2.

Immunohistochemical localisation of PrPC and LRP1 on sensory neurons. (A,B) Immunolabelling for cell-surface PrPC with 2S Alexa-Fluor-594–Fab (red), 3 μm (A) and 9 μm (B) above the plane of the laminin substrate. PrPC-expressing neurons (1-3; arrowheads point to their surface labelling), plus axons (arrows), and PrPC-negative substrate cells (visible by their blue DAPI-stained chromatin, asterisks) can be seen in (A); only their cell bodies are visible in B. These images are from a series (supplementary material Fig. S1), collected every 100 nm in vertical steps, which were deconvolved and assembled into ascending stacks of ten sections (i.e. 1 μm optical sections). Neuronal cell bodies shown subsequently in this paper are combined from stacks of 10-30 images taken at a level corresponding to B, with DAPI-stained chromatin. (C,D) Surface immunolabelling of PrPC (2S Alexa-Fluor-594–Fab, red) and green Alexa-Fluor-488-labelled anti-LRP1 (C) or Ctx (D) on sensory neurons fixed at 37°C before immunolabelling. On the cells shown, 37% and 77% of PrP colocalised with LRP1 and Ctx (data are in supplementary material Tables S1a and S1b). (E) Neuron with surface PrPC prelabelled at 10°C with Alexa-Fluor-594–Fab (red), then allowed to endocytose at 37°C for 1 minute, then fixed, permeabilised and immunolabelled for LRP1. It had endocytosed 82% of its labelled PrPC, most to perinuclear tubular structures (yellow owing to colocalised LRP1); arrow points to labelled PrPC still on the surface. (F) Transmission EM showing labelling within a coated pit on a neuron that has endocytosed (1.5 minutes at 37°C) its prelabelled 5 nm gold-Fab to PrPC, and 10 nm gold-α2M*. Bars, 5 μm (A,C-E), 100 nm (F).

Fig. 2.

Immunohistochemical localisation of PrPC and LRP1 on sensory neurons. (A,B) Immunolabelling for cell-surface PrPC with 2S Alexa-Fluor-594–Fab (red), 3 μm (A) and 9 μm (B) above the plane of the laminin substrate. PrPC-expressing neurons (1-3; arrowheads point to their surface labelling), plus axons (arrows), and PrPC-negative substrate cells (visible by their blue DAPI-stained chromatin, asterisks) can be seen in (A); only their cell bodies are visible in B. These images are from a series (supplementary material Fig. S1), collected every 100 nm in vertical steps, which were deconvolved and assembled into ascending stacks of ten sections (i.e. 1 μm optical sections). Neuronal cell bodies shown subsequently in this paper are combined from stacks of 10-30 images taken at a level corresponding to B, with DAPI-stained chromatin. (C,D) Surface immunolabelling of PrPC (2S Alexa-Fluor-594–Fab, red) and green Alexa-Fluor-488-labelled anti-LRP1 (C) or Ctx (D) on sensory neurons fixed at 37°C before immunolabelling. On the cells shown, 37% and 77% of PrP colocalised with LRP1 and Ctx (data are in supplementary material Tables S1a and S1b). (E) Neuron with surface PrPC prelabelled at 10°C with Alexa-Fluor-594–Fab (red), then allowed to endocytose at 37°C for 1 minute, then fixed, permeabilised and immunolabelled for LRP1. It had endocytosed 82% of its labelled PrPC, most to perinuclear tubular structures (yellow owing to colocalised LRP1); arrow points to labelled PrPC still on the surface. (F) Transmission EM showing labelling within a coated pit on a neuron that has endocytosed (1.5 minutes at 37°C) its prelabelled 5 nm gold-Fab to PrPC, and 10 nm gold-α2M*. Bars, 5 μm (A,C-E), 100 nm (F).

Fig. 2C is an immunofluorescent view of the relative distribution of LRP1 and PrPC on the surface of a cultured adult sensory neuron. Partial colocalisation of the two proteins was found, with 40% of PrPC overlapping LRP1 (Table 1; conversely, 43.2±14.7% of surface LRP1 colocalised with PrPC). Somewhat higher colocalisation (54.2±21.6%) was seen between PrPC and the lipid `raft' marker ganglioside GM1 labelled with the cholera toxin B chain (Ctx; Fig. 2D). Antibodies against other neuronally expressed LRP family members (LRP1b, LRP6, LRP8 and VLDLR) failed to react with sensory neurons assessed by immunoblotting or immunohistochemistry.

Table 1.

Immunofluorescent colocalisation with LRP1 of PrPC, prelabelled with Alexa-Fluor-594 Fab, remaining on the surface during endocytosis

Time at 37°C % PrP colocalised with LRP1 % Fab-labelled PrPC still on surface
0 minutes   40.6±18.9, n=8   82.4±14.4  
1 minutes   60.1±13.9*, n=9   49.2±20.0  
2 minutes   97.7±2.9**, n=14   13.3±6.9  
Time at 37°C % PrP colocalised with LRP1 % Fab-labelled PrPC still on surface
0 minutes   40.6±18.9, n=8   82.4±14.4  
1 minutes   60.1±13.9*, n=9   49.2±20.0  
2 minutes   97.7±2.9**, n=14   13.3±6.9  

Mean percentage (± s.d.)

*

P<0.05 and

**

P<0.001, significantly different from 0-minute value. For experimental data, see supplementary material Table S1a

To gain a more dynamic view of the proximity of the two proteins during endocytosis, surface PrPC was prelabelled at 10°C with monovalent 2S Alexa-Fluor-594–Fab to PrPC; the cells were then washed to remove unbound Fab and placed at 37°C. The pulse-labelled PrPC was endocytosed rapidly over the next 2 minutes (Fig. 2E), a period during which labelled PrPC remaining on the cell surface colocalised increasingly with LRP1 (Table 1).

The proximity of PrPC to LRP1 during endocytosis was analysed at higher resolution by examining, by transmission electron microscopy (EM), neurons that were prelabelled for PrPC with 5 nm Fab gold, and for LRP1 by its ligand, activated α2macroglobulin (α2M*), attached to 10 nm gold. Also, for comparison with PrPC, the transferrin (Tf) receptor was labelled with Tf coupled to 10 nm gold. After endocytosis for 1.5 minutes at 37°C, within the restricted confines of coated pits, 66.2% of PrPC label was within 50 nm of α2M* (Fig. 2F), but only 24.3% was within 50 nm of the Tf label. The converse selective association of the ligands with PrPC also held: 84.7% of α2M* was within 50 nm of PrPC, compared with only 35.4% of Tf. Thus, within this morphologically identifiable endocytic compartment, PrPC was more closely associated with an LRP1 ligand than with a ligand for an independently endocytosed receptor.

Inhibition of the endocytosis of PrPC by recombinant RAP and siRNALRP1

To assess inhibition of endocytosis, neurons were prelabelled for surface PrPC with 2S Alexa 594-Fab; as a positive control, their Tf receptors were labelled with Alexa-Fluor-488–Tf. Preincubation with recombinant RAP inhibited endocytosis of PrPC but not Tf (Fig. 3A,B; Table 2).

Table 2.

Inhibition of endocytosis of PrPC and Tf by RAP and siRNA

Inhibiting agent % PrPC internalised % Tf internalised
Vehicle control   93.2±1.6   93.0±2.3  
+80 nM RAP   64.5±4.1**  88.2±7.2  
+1 μM RAP   29.1±5.0**  94.5±0.5  
siRNACon  84.9±15.0   87.5±10.9  
siRNALRP1.1  47.1±14.2**  80.5±13.4  
siRNALRP1.2  63.0±26.3**  85.2±7.1  
siRNALRP1.3  68.5±16.2*  82.7±11.9  
Inhibiting agent % PrPC internalised % Tf internalised
Vehicle control   93.2±1.6   93.0±2.3  
+80 nM RAP   64.5±4.1**  88.2±7.2  
+1 μM RAP   29.1±5.0**  94.5±0.5  
siRNACon  84.9±15.0   87.5±10.9  
siRNALRP1.1  47.1±14.2**  80.5±13.4  
siRNALRP1.2  63.0±26.3**  85.2±7.1  
siRNALRP1.3  68.5±16.2*  82.7±11.9  

Mean ± s.d. of surface-labelled PrPC or Tf internalised in 2 minutes at 37°C; significant differences from control values

*

P<0.01 and

**

P<0.001. For experimental data, see supplementary material Tables S2a, S2b, S2c and S2d

To circumvent long-term disruption of neuronal metabolism by stable inhibition of LRP1 expression, transient knockdown of LRP1 was achieved using the antennapedia peptide penetratin-1 to deliver one of three siRNAs specific for LRP1 (siRNALRP1.1, siRNALRP1.2, siRNALRP1.3) or a control (siRNACon). The siRNALRP1.1 produced rapid knockdown of LRP1 protein (Fig. 3E-H) that was followed by several-fold overexpression by 72 hours (data not shown). For inhibition of endocytosis, 90 minutes of treatment of sensory neurons with the siRNA-penetratin conjugate was used, as each of the three siRNAs directed against LRP1 lowered expression of LRP1 protein by 30-50% within this period without affecting the level of surface PrPC, as determined by quantitative analysis of immunofluorescent binding to surface PrPC and total cellular LRP1 (Fig. 3E,F). For example, in an experiment in which siRNALRP1.1 lowered expression of LRP1 to 64.0% of the control level (P=0.003), the level of surface PrPC on the two sets of cells was identical (P=0.98; supplementary material Table S2c). With this brief downregulation of LRP1, all three siRNALRP1 constructs significantly inhibited the endocytosis of PrPC but not Tf (Table 2; Fig. 3C,D).

Fig. 3.

Inhibition of endocytosis of PrPC on sensory neurons by RAP and siRNALRP1. (A,B) 1 μM RAP (B; A is vehicle control) inhibits the endocytosis of neuronal surface-labelled PrPC (red) but not Tf (green) after 2 minutes at 37°C. (C,D) Neurons treated for 90 minutes with 250 nM siRNACon (C) or siRNALRP1.1 (D) before endocytosing surface-labelled PrPC (red) and Tf (green) for 2 minutes at 37°C. (E,F) Immunocytochemical labelling of surface PrPC (red) and total LRP1 (green) in neurons preincubated for 90 minutes with 250 nM siRNACon (E) or siRNALRP1 (F), used to assess the effect of LRP1 knockdown; data in supplementary material Tables S2c and S2d. Bars, 5 μm. (G,H) Reduction of LRP1 protein shown by immunoblot (G; the 515-kDa band is shown) and quantitated in H (mean band intensity normalised to actin, ±s.d., n=4 independent knockdown experiments) after 250 nM penetratin-siRNA addition for the times shown (plus a 4-hour point showing the effect of adding additional 250 nM siRNA at 2 hours). The samples shown in G were from the 4-hour time point with two additions of siRNA.

Fig. 3.

Inhibition of endocytosis of PrPC on sensory neurons by RAP and siRNALRP1. (A,B) 1 μM RAP (B; A is vehicle control) inhibits the endocytosis of neuronal surface-labelled PrPC (red) but not Tf (green) after 2 minutes at 37°C. (C,D) Neurons treated for 90 minutes with 250 nM siRNACon (C) or siRNALRP1.1 (D) before endocytosing surface-labelled PrPC (red) and Tf (green) for 2 minutes at 37°C. (E,F) Immunocytochemical labelling of surface PrPC (red) and total LRP1 (green) in neurons preincubated for 90 minutes with 250 nM siRNACon (E) or siRNALRP1 (F), used to assess the effect of LRP1 knockdown; data in supplementary material Tables S2c and S2d. Bars, 5 μm. (G,H) Reduction of LRP1 protein shown by immunoblot (G; the 515-kDa band is shown) and quantitated in H (mean band intensity normalised to actin, ±s.d., n=4 independent knockdown experiments) after 250 nM penetratin-siRNA addition for the times shown (plus a 4-hour point showing the effect of adding additional 250 nM siRNA at 2 hours). The samples shown in G were from the 4-hour time point with two additions of siRNA.

Fig. 4.

Effect of 4 hours of treatment with siRNALRP1 upon PrPC distribution within neurons, and upon LRP1-dependent endocytosis. (A-D) Neurons pretreated with 250 nM siRNACon (A), or with siRNALRP1.1 (B), siRNALRP1.2 (C) or siRNALRP1.3 (D), were surface labelled with Alexa-Fluor-488–2S Fab anti-PrP (green), then fixed and permeabilised for labelling internal PrPC with Alexa-Fluor-594–SAF83 (red). Quantitation is given in supplementary material Table S4a. (E,F) Neurons treated as above with siRNACon (E) or siRNALRP1.1 (F), fixed, permeabilised and labelled (both surface and internal) with Alexa-Fluor-488 anti-Thy-1 antibody (green). Quantitation is given in supplementary material Table S3b. (G,H) Neurons treated with siRNACon (G) or siRNALRP1.1 (H) were prelabelled with Alexa-Fluor-488 α2M* (green) and Texas Red-Tf and then placed at 37°C for 2 minutes. (I,J) Neurons treated with siRNACon (I) or siRNALRP1.1 (J) were prelabelled for PrPC with Alexa-Fluor-594–Fab (red), and the transferrin receptor with Alexa-Fluor-488–Tf (green), and placed at 37°C for 2 minutes. Bars, 5 μm.

Fig. 4.

Effect of 4 hours of treatment with siRNALRP1 upon PrPC distribution within neurons, and upon LRP1-dependent endocytosis. (A-D) Neurons pretreated with 250 nM siRNACon (A), or with siRNALRP1.1 (B), siRNALRP1.2 (C) or siRNALRP1.3 (D), were surface labelled with Alexa-Fluor-488–2S Fab anti-PrP (green), then fixed and permeabilised for labelling internal PrPC with Alexa-Fluor-594–SAF83 (red). Quantitation is given in supplementary material Table S4a. (E,F) Neurons treated as above with siRNACon (E) or siRNALRP1.1 (F), fixed, permeabilised and labelled (both surface and internal) with Alexa-Fluor-488 anti-Thy-1 antibody (green). Quantitation is given in supplementary material Table S3b. (G,H) Neurons treated with siRNACon (G) or siRNALRP1.1 (H) were prelabelled with Alexa-Fluor-488 α2M* (green) and Texas Red-Tf and then placed at 37°C for 2 minutes. (I,J) Neurons treated with siRNACon (I) or siRNALRP1.1 (J) were prelabelled for PrPC with Alexa-Fluor-594–Fab (red), and the transferrin receptor with Alexa-Fluor-488–Tf (green), and placed at 37°C for 2 minutes. Bars, 5 μm.

Sustained inhibition of LRP1 lowers the level, but not endocytosis, of surface PrPC

Exposure of neurons to siRNALRP1.1 for 2-4 hours reduced LRP1 levels by ∼75% (Fig. 3G,H). This was accompanied by a marked reduction in surface PrPC, to 43.9±8.1% of siRNACon-treated cells within 4 hours, as determined by immunolabelling of live cells at 10°C (Fig. 4A-D; P<0.001; supplementary material Table S3a). This treatment increased the surface level of GPI-anchored Thy-1 (Fig. 4E,F) by 2.2±1.2 fold compared with controls (P=0.04; supplementary material Table S3b). The increased Thy-1 was evident in immunoblots, as was an even larger increase in APP (Fig. 5).

Sustained reduction of LRP1 levels did not affect the ability of the residual surface LRP1 to be endocytosed, as shown by the complete internalisation within 2 minutes of much reduced levels of its ligand, α2M* (Fig. 4G,H). Similarly, the reduced level of surface PrPC was >80% endocytosed within 2 minutes (Fig. 4I,J), giving a reduced amount of PrPC endocytosed without any discernible reduction in its rate of endocytosis.

Sustained inhibition of LRP1 increases PrPC in biosynthetic compartments

However, siRNALRP1 inhibition for 4 hours was accompanied not only by a loss in surface PrPC but also by a 3.5±0.9 (P<0.01) fold increase in intracellular PrPC (Fig. 4A-D). Intracellular Thy-1 was not elevated (Fig. 4E,F).

Most of the increased intracellular PrPC colocalised with early biosynthetic compartments (Table 3; Fig. 6). The chaperone BiP was used as a marker of the endoplasmic reticulum (ER); α-mannosidase II as a marker for the mid-Golgi, and syntaxin 6 as a marker for the trans-Golgi. The levels of the latter two did not differ between siRNACon and siRNALRP1.1-treated cells (P>0.5), but BiP levels were elevated 4.4±0.9 fold (P<0.05), suggesting that an ER stress response had been induced. However, the proportion of intracellular PrPC that colocalised with BiP was nearly halved in the siRNALRP1.1-treated cells (Table 3), so this compartment contained 1.9 fold the normal PrPC level. The mid- and trans-Golgi retained their normal share of intracellular PrPC (and so contained 3.5 times their normal PrPC).

Table 3.

Effect of decreasing LRP1 with respect to PrPC upon the colocalisation of PrPC with markers of biosynthetic compartments in sensory neurons

Neurons (modification) Modifier % BiP (ER) % α-Mannosidase II (mid-Golgi) % Syntaxin 6 (trans-Golgi)
WT (control)   siRNACon  54.6±22.1   22.1±9.5   25.5±17.7  
WT (LRP1 lowered)   siRNALRP1.1  29.9±18.3*  23.3±7.0   18.3±10.7  
Tg20 (PrPC raised)   Transgenic overexpression   27.4±5.8*  25.2±8.9   20.3±4.4  
Neurons (modification) Modifier % BiP (ER) % α-Mannosidase II (mid-Golgi) % Syntaxin 6 (trans-Golgi)
WT (control)   siRNACon  54.6±22.1   22.1±9.5   25.5±17.7  
WT (LRP1 lowered)   siRNALRP1.1  29.9±18.3*  23.3±7.0   18.3±10.7  
Tg20 (PrPC raised)   Transgenic overexpression   27.4±5.8*  25.2±8.9   20.3±4.4  

For experimental data, see supplementary material Tables S4a and S4b

*

P<0.05, significant differences from control values

Fig. 5.

Effect of prolonged downregulation of LRP1 on the neuronal proteins Thy-1 and APP. Immunoblots, with the neurofilament light chain used as a loading control, of cells treated for 5 hours with two additions of 250 nM siRNA, control (left) and LRP1.1 (right).

Fig. 5.

Effect of prolonged downregulation of LRP1 on the neuronal proteins Thy-1 and APP. Immunoblots, with the neurofilament light chain used as a loading control, of cells treated for 5 hours with two additions of 250 nM siRNA, control (left) and LRP1.1 (right).

Fig. 6.

Effect of lowering LRP1 levels upon internal PrPC in sensory neurons. (A-F) Neurons treated for 4 hours with 250 nM siRNACon (A,C,E) or siRNALRP1.1 (B,D,F) were fixed, permeabilised and immunolabelled for PrPC (green) and (in red) BiP (A,B), α-mannosidase II (C,D) or syntaxin 6 (E,F). Bars, 5 μm.

Fig. 6.

Effect of lowering LRP1 levels upon internal PrPC in sensory neurons. (A-F) Neurons treated for 4 hours with 250 nM siRNACon (A,C,E) or siRNALRP1.1 (B,D,F) were fixed, permeabilised and immunolabelled for PrPC (green) and (in red) BiP (A,B), α-mannosidase II (C,D) or syntaxin 6 (E,F). Bars, 5 μm.

Increased intracellular PrPC is not induced by ER stress

To test whether the accumulation of PrPC along biosynthetic pathways is due to an ER stress response, neurons were heat-shocked at 39°C for 4 hours. BiP levels were elevated 2.5 fold compared with their basal levels at 37°C (P=0.015). There was a minor, insignificant decrease in both surface and intracellular PrPC levels (supplementary material Fig. S2 and supplementary material Tables S5a and S5b).

Increased PrPC expression mirrors decreased LRP1 expression in its effects upon PrPC trafficking

Transgenic overexpression of PrPC, in lowering the ratio of LRP1:PrPC, should affect PrPC trafficking in the same way as downregulation of LRP1 if the latter is an obligate trafficking partner. Sensory neurons from PrPC-overexpressing Tg20 mice were found to have 14-fold higher PrPC levels than genetically wild-type (WT) neurons (similar to the increased expression reported in brain) (Fischer et al., 1996) and a much smaller (1.8 fold) elevation in their LRP1 level. As a result, Tg20 neurons have an eightfold higher than normal ratio of PrPC to LRP1 (supplementary material Table S6a).

The excess PrPC was evident in the time taken by Tg20 sensory neurons to endocytose their surface-labelled PrPC. WT neurons internalised >80% of surface-labelled PrPC within 2 minutes at 37°C, irrespective of the level of surface PrPC they expressed (which varied over a tenfold range; Fig. 7A, left panel). Tg20 PrPC-overexpressing neurons internalised only a small proportion of their surface-labelled PrPC at this stage, with a strong inverse correlation between the level of PrPC expressed and the proportion endocytosed (Fig. 7A, right panel). Even after 6 minutes at 37°C, the highest PrPC-expressing Tg20 neurons still had ∼40% left on their surface (Fig. 7A,B; Table 4). This endocytosis of PrPC was strongly inhibited by siRNALRP1.1 (Fig. 7B,C; Table 4). Thus, at high levels of overexpression of PrPC, the expression level of LRP1 becomes rate limiting for PrPC.

Table 4.

Proportion of surface-labelled PrPC and Tf internalised after 6 minutes at 37°C by normal (WT) and transgenic overexpressing (Tg20) neurons

siRNACon
siRNALRP1.1
% PrPC % Tf % PrPC % Tf
WT   83.7±17.5   92.4±5.3   35.8±18.5**  83.4±11.4  
Tg 20   58.5±35.3   88.1±8.7   37.4±23.8*  69.3±20.8  
siRNACon
siRNALRP1.1
% PrPC % Tf % PrPC % Tf
WT   83.7±17.5   92.4±5.3   35.8±18.5**  83.4±11.4  
Tg 20   58.5±35.3   88.1±8.7   37.4±23.8*  69.3±20.8  

Mean ± s.d. shown

*

P<0.1 and

**

P<0.001, significantly different from the siRNACon values

Transgenic overexpression of PrPC also selectively increased intracellular PrPC, evident by comparing the ratio of the intensity of immunofluorescent labelling of internal to surface PrPC in optical cross-sections of neurons (Fig. 7D,E). This ratio was 1.4±1.3 for WT cells, compared with 5.0±1.5 for Tg20 neurons (Table 5), indicating a selective intracellular accumulation of PrPC at the expense of surface levels in the overexpressing neurons. This mirrors the accumulation of intracellular PrPC in biosynthetic compartments seen following LRP1 downregulation by prolonged siRNALRP1-treatment, including the accumulation of excess PrPC primarily in post-ER compartments (Table 3). In the case of Tg20 neurons, however, there is no elevation in BiP levels (P=0.47; supplementary material Table S6b).

Table 5.

Ratio of internal PrP to surface PrP for WT and Tg20 neurons

Cell no. WT Tg20
1   1.17   5.37  
2   2.61   5.24  
3   0.69   3.73  
4   3.20   4.15  
5   1.26   3.01  
6   0.35   5.54  
7   0.17   4.89  
8    7.90  
Average   1.4   5.0  
± s.d.   1.3   1.5  
t test, P=   0.0001   
Cell no. WT Tg20
1   1.17   5.37  
2   2.61   5.24  
3   0.69   3.73  
4   3.20   4.15  
5   1.26   3.01  
6   0.35   5.54  
7   0.17   4.89  
8    7.90  
Average   1.4   5.0  
± s.d.   1.3   1.5  
t test, P=   0.0001   

The ratio of internal PrPC to surface PrPC is shown for individual cells, determined by differential immunolabelling of surface and internal PrPC, as shown in Fig. 4A-D 

Fig. 7.

Effect of overexpression of PrPC upon its endocytic and biosynthetic trafficking. (A) The percentage of surface-labelled PrPC on WT (left panel) and Tg20 neurons (right panel) that has been endocytosed is plotted as a function of their relative level of surface PrPC (measured as the fluorescence intensity of Alexa-Fluor-594–2S Fab bound per μm3). The correlation coefficient ρ and its significance (p) are shown. To avoid saturation of the camera by the 14-fold brighter fluorescence of Tg20 neurons, excitation intensity was turned down to give an overall fluorescence measured that was approximately comparable for the two sets of neurons. (B,C) tg20 neurons, treated for 90 minutes with siRNACon (B) or siRNALRP1.1 (C), labelled with 2S Alexa-Fluor-594–Fab (red) and Alexa-Fluor-488–Tf (green) were placed at 37°C for 6 minutes. In the control cell shown, 50% of the labelled PrPC has been internalised, and 35% in the siRNALRP1.1-treated cell. (D,E) Examples of immunolabelling of WT (D) and Tg20 (E) neurons for cell-surface PrP (Alexa-Fluor-488–2S fab; green) and internal PrPC (Alexa-Fluor-594–SAF83, red). Bars, 5 μm.

Fig. 7.

Effect of overexpression of PrPC upon its endocytic and biosynthetic trafficking. (A) The percentage of surface-labelled PrPC on WT (left panel) and Tg20 neurons (right panel) that has been endocytosed is plotted as a function of their relative level of surface PrPC (measured as the fluorescence intensity of Alexa-Fluor-594–2S Fab bound per μm3). The correlation coefficient ρ and its significance (p) are shown. To avoid saturation of the camera by the 14-fold brighter fluorescence of Tg20 neurons, excitation intensity was turned down to give an overall fluorescence measured that was approximately comparable for the two sets of neurons. (B,C) tg20 neurons, treated for 90 minutes with siRNACon (B) or siRNALRP1.1 (C), labelled with 2S Alexa-Fluor-594–Fab (red) and Alexa-Fluor-488–Tf (green) were placed at 37°C for 6 minutes. In the control cell shown, 50% of the labelled PrPC has been internalised, and 35% in the siRNALRP1.1-treated cell. (D,E) Examples of immunolabelling of WT (D) and Tg20 (E) neurons for cell-surface PrP (Alexa-Fluor-488–2S fab; green) and internal PrPC (Alexa-Fluor-594–SAF83, red). Bars, 5 μm.

Fig. 8.

Biochemical analysis of interaction between PrPC and LRP1 on sensory neurons. (A) Immunoblot for PrP and Thy-1 of sequential immunoprecipitates (IP) of surface then internal antigen using antibody against PrPC or LRP1. The large arrow denotes the major 37-kDa di-glycosylated surface form of PrPC, the mid-size arrow shows monoglycosylated PrPC, and the small arrow shows non-glycosylated 23-kDa PrPC. PrP immunoblots are from the same gel, with duplicate samples run separately for Thy-1. (B) Immunoprecipitates for internal PrP or LRP1 (from part A) were diluted in endo H digestion buffer and either digested or not with the glycosidase, as indicated, before being immunoblotted for PrP. Arrows denote the relevant PrPC glycoforms as in A; the asterisk denotes the (slanted) band of endo H enzyme that binds antibodies nonspecifically.

Fig. 8.

Biochemical analysis of interaction between PrPC and LRP1 on sensory neurons. (A) Immunoblot for PrP and Thy-1 of sequential immunoprecipitates (IP) of surface then internal antigen using antibody against PrPC or LRP1. The large arrow denotes the major 37-kDa di-glycosylated surface form of PrPC, the mid-size arrow shows monoglycosylated PrPC, and the small arrow shows non-glycosylated 23-kDa PrPC. PrP immunoblots are from the same gel, with duplicate samples run separately for Thy-1. (B) Immunoprecipitates for internal PrP or LRP1 (from part A) were diluted in endo H digestion buffer and either digested or not with the glycosidase, as indicated, before being immunoblotted for PrP. Arrows denote the relevant PrPC glycoforms as in A; the asterisk denotes the (slanted) band of endo H enzyme that binds antibodies nonspecifically.

LRP1 and PrPC interact on the surface and within biosynthetic compartments of normal sensory neurons

To assess biochemically whether PrPC could interact with LRP1 on the cell surface and in intracellular compartments of normal, untreated sensory neurons, LRP1 was sequentially immunoprecipitated from the surface, and then from internal compartments, of these cells (Fig. 8A). A subset of surface PrPC co-immunoprecipitated with LRP1 (Fig. 8A, lane 2 compared with lane 1). There was no co-immunoprecipitation of Thy-1, the major neuronal GPI-anchored surface protein with PrPC or LRP1 (lanes 1′and 2′; total Thy-1 is in the unbound fractions, lanes 5′ and 6′).

The major proportion of PrPC on the sensory neurons was immunoprecipitated from internal compartments (Fig. 8A, lane 3 compared with lane 1, with unbound PrPC shown in lane 5). A substantial proportion of internal PrPC co-immunoprecipitated with LRP1 (Fig. 8A, lane 4 compared with lane 3), although a major part did not (unbound fraction in lane 6).

To identify whether any of the PrPC associated with LRP1 was in the ER, samples immunoprecipitated by antibodies against either PrPC or LRP1 were subjected to control or endoglycosidase H (endoH) digestion and then electrophoresed and immunoblotted for PrPC. It is difficult to discern an endoH-sensitive band within total PrPC (Fig. 8B, lanes 1 and 2), whereas, in the proportion of PrPC co-immunoprecipitated with LRP1, there was an increase in fully deglycosylated PrPC after endoH treatment (Fig. 8B, lanes 3 and 4), suggesting an ER origin of part of the PrPC bound to LRP1 in normal sensory neurons.

The N-terminal domain of PrPC is a high affinity LRP1 ligand

As the N-terminal domain of PrPC is flexible and does not interact structurally with the C-terminal domain (Hornemann et al., 2004), the interaction with purified human placental LRP1 of the N-terminal residues 23-107 of PrPC, isolated as a GST fusion protein (GST-PrP23-107), was determined by surface plasmon resonance (SPR). The N-terminal domain bound with high affinity to LRP1 (Fig. 9A). The binding affinity was calculated from the estimated association (Ka=2.75×104 M–1s–1) and dissociation (Kd=5.44×10–4 s–1) rate constants as KD=Kd/Ka=20 nM (Fig. 9A). Similar affinities were measured in the range of 70–350 nM ligand. This binding was strongly inhibited by chelating Ca2+ or lowering the pH to 6.0 (data not shown), as expected for an LRP1 ligand (Fisher et al., 2006; Herz et al., 1988; Moestrup et al., 1993a). Of particular interest was the ability of PrPC to compete with RAP. RAP at 1 μM rapidly saturated LRP1; with RAP prebound and its concentration held at 1 μM, further addition of GST-PrP23-107 at 100 nM bound to LRP1 to 45% of its control level (Fig. 9B). This demonstrates a remarkable ability of the N-terminal domain of PrP to bind to LRP1 in the presence of its biosynthetic chaperone.

Fig. 9.

Surface plasmon resonance (SPR) analysis of the binding of GST-PrP23-107 to human LRP1. (A) Binding of 350 nM GST-PrP23-107 compared with GST; dissociation started at 600 seconds. (B) Binding of 1 μM RAP, with a second addition of 1 μM RAP without (solid upper line) or with 100 nM GST-PrP23-107 (dashed line); binding of 100 nM GST-PrP23-107 alone is shown in the lower solid trace; dissociation started at 1150 seconds.

Fig. 9.

Surface plasmon resonance (SPR) analysis of the binding of GST-PrP23-107 to human LRP1. (A) Binding of 350 nM GST-PrP23-107 compared with GST; dissociation started at 600 seconds. (B) Binding of 1 μM RAP, with a second addition of 1 μM RAP without (solid upper line) or with 100 nM GST-PrP23-107 (dashed line); binding of 100 nM GST-PrP23-107 alone is shown in the lower solid trace; dissociation started at 1150 seconds.

The role of LRP1 in surface trafficking of PrPC

The rapid and constitutive endocytosis of PrPC on sensory neurons was inhibited by the downregulation of LRP1 by three specific siRNAs; physical association was found by co-immunoprecipitation of PrPC and LRP1 on the neuronal surface, confirming fluorescence and EM immunocytochemical colocalisation that increased during the process of endocytosis; and the N-terminal domain of PrPC, responsible for its endocytosis (Shyng et al., 1995a; Sunyach et al., 2003), bound with high affinity to LRP1. In addition, RAP inhibited PrPC endocytosis, although unexpectedly high concentrations were needed; 80 nM is normally sufficient to inhibit binding of ligands to LRP1 [e.g. this concentration inhibits 90% of the binding of prion fibrils to sensory neurons (C.J.P., unpublished)], yet, in its presence, 60% of surface PrPC was still internalised. Even at 1 μM RAP, 30% of PrPC was still endocytosed within 2 minutes, in comparison with the 55% inhibition of GST-PrP23-107 by this concentration of RAP. Inhibition of PrPC by RAP occurs but is atypical for an LRP ligand. Overall, however, converging lines of evidence argue that LRP1 is the key endocytic partner of PrPC on these neurons.

This conclusion is perhaps not unexpected, given the role of LRP1 in mediating the endocytosis of the GPI-anchored plasminogen activator receptor (Horn et al., 1998). Furthermore, Taylor and Hooper (Taylor and Hooper, 2007) reported that siRNALRP1 knockdown of LRP1 inhibits the 100 μM Cu2+-dependent endocytosis of exogenous transfection-expressed PrPC on SH-SY5Y cells. These authors showed reduced internalisation of PrPC in the presence of siRNALRP1 compared with untreated cells, without testing whether their long-term siRNALRP1 treatment reduced surface expression of PrPC. In the light of our data, it would seem premature to conclude that it is the Cu2+-dependent endocytosis of PrPC, rather than its surface level, that is reduced by lowering LRP1 levels in SH-SY5Y cells.

Given the diverse roles of LRP1 in controlling neuronal lipid metabolism and surface proteins (Herz and Chen, 2006; May and Herz, 2003), separating direct from indirect effects of modulating LRP1 expression is not trivial. Not only did sustained reduction of LRP1 halve the level of surface PrPC, it elevated Thy-1 and particularly APP levels. The latter was expected as LRP1 controls the degradation of APP (Pietrzik et al., 2004; Zerbinatti et al., 2004), but the former, not so. There is no known interaction between LRP1 and Thy-1 on the cell surface (they do not co-immunoprecipitate and, as Thy-1 is not rapidly endocytosed, they are most unlikely to interact). Possibly GPI-anchored proteins compete for a rate-limiting step in transport from the trans-Golgi to the cell surface, so that Thy-1 would benefit from lowered PrPC traffic.

We have previously noted that the surface environment of PrPC on neurons is complex, with PrPC leaving its detergent-resistant domains to traverse normal (detergent soluble) membrane for endocytosis (Brügger et al., 2004; Madore et al., 1999; Sunyach et al., 2003). This complexity is evident in the colocalisation of 50% of PrPC with the lipid `raft' marker ganglioside GM1 (compare the ∼70% distribution of PrPC in detergent-resistant membrane) (Madore et al., 1999; Sunyach et al., 2003), and the increasing colocalisation of PrPC with LRP1 as endocytosis progresses. We have been unable to determine whether LRP1 is within detergent-soluble or -insoluble membranes on the surface of sensory neurons because it is too readily proteolysed in detergent extracts from these cells. However, we can find no LRP1 at all within detergent-insoluble membrane fractions from brain membranes (E.G.M.V., unpublished). On myoblasts and Chinese hamster ovary (CHO) cells, LRP1 is similarly located not within detergent-resistant membranes, although it is reported to transit briefly detergent-resistant, before entering detergent-soluble, membranes for endocytosis on mouse embryonic fibroblasts (Wu and Gonias, 2005). We suspect that LRP1 does not physically enter neuronal rafts, although it might not need to in order to bind to raft-associated PrPC as it is so large it could readily extend over the 40-100 nm diameter (Kusumi et al., 2005) of membrane rafts.

The LRP1-PrPC interaction in vivo might limit the endocytosis of both

The size of LRP1 might lead to quite a different role for the PrPC-LRP1 interaction in vivo from the endocytic one described here. LRP1 is so massive it could multiply-span the normal intercellular spaces of adult brain. It is more than four times larger than N-cadherin that homotypically binds to itself across the ∼20 nm gap of central nervous system (CNS) synaptic clefts (Bruses, 2006; Zuber et al., 2005). In the closely packed confines of the CNS, LRP1 could bind to PrPC on an adjacent, as readily as its own, cell surface. This would produce the opposite function to that studied in our isolated cell system – intercellular binding between PrPC and LRP1 presumably would prevent the endocytic trafficking of both, retaining each on the apposed surfaces until the binding of other soluble ligands (e.g. astrocyte-derived ApoE) displaced PrPC to allow LRP1 to internalise the newly bound cargo.

This study specifically concentrated upon isolated neuronal cell bodies, devoid of attachment to other cells. Nonetheless, occasionally two neuronal cell bodies were in contact, and at such points distinct immunolabelled PrPC remained on the surface after 2 minutes at 37°C (data not shown). The possibility that intercellular interactions between PrPC and LRP1 stabilise both molecules to their apposed surfaces needs to be further investigated with cells in contact. Intercellular ligand binding functions have been proposed for PrPC (e.g. Mange et al., 2002; Shmerling et al., 1998). Intercellular restriction of LRP1 trafficking by PrPC might be particularly important at synapses, where the intracellular domain of LRP1 can organise the distribution of postsynaptic receptors through linking adaptors such as PSD95 (Herz and Chen, 2006).

Intercellular binding by LRP1-PrPC, in restricting endocytic trafficking of both, would presumably increase the half-life of LRP1 on sensory neurons from the ∼1 hour implied by our siRNA inhibition towards the 3 hours measured on HepG2 cells (Melman et al., 2002).

LRP1 as a co-receptor for PrPC during biosynthetic transport

Members of the LRP family of receptors, each with multiple high-affinity binding sites for secreted and surface membrane proteins, form massive complexes with their ligands in the ER that prevent export to the Golgi unless their binding sites are masked by RAP (Willnow et al., 1996). This client-specific chaperone binds to nascent LRP1 as it emerges into the ER lumen (Bu and Rennke, 1996) and remains bound until LRP1 reaches the trans-Golgi (Lee et al., 2006), where the acidic (pH 5.8) environment dissociates RAP (which is retrieved by ERD2 to the ER) (Bu et al., 1997), leaving activated LRP1 to proceed to the cell surface.

LRP1 co-immunoprecipitates endoH-sensitive PrPC from normal sensory neurons, indicating a direct interaction between these proteins in the ER. PrPC must therefore be able to bind to LRP1 in the presence of RAP in biosynthetic compartments, a property demonstrated by SPR by the ability of GST-PrP23-107 to bind at 45% normal capacity to LRP1 in the presence of 1 μM RAP. This, we believe, is the only reported case of a ligand binding to LRP1 in the presence of RAP. Moestrup and colleagues have extensively studied by SPR the binding kinetics of LRP family ligands. RAP has been used as a standard control and has in all previous cases completely inhibited, at 1 μM, all ligand binding (e.g. Moestrup et al., 1998; Nykjaer et al., 2001).

What is unexpected is that this interaction enhances the progress of PrPC through biosynthetic compartments. LRP1 has been observed to promote the biosynthetic trafficking of β1 integrin to the cell surface, although direct contact between the receptor and the integrin could not be demonstrated (Salicioni et al., 2004). With levels of LRP1 reduced, high levels of PrPC accumulated in biosynthetic compartments up to, and including, the trans-Golgi. Sustained reduction of LRP1 levels also induced high BiP levels, indicative of a stress response. However, intracellular accumulation of PrPC was not observed by heat-shock alone, and was found with transgenic neurons with highly elevated levels of PrPC but not LRP1 (or BiP). Taken together, these data argue for a functional role for LRP1 in expediting the biosynthetic trafficking of PrPC.

A block in PrPC biosynthetic trafficking at an endoH-insensitive stage occurs following deletion of N-terminal residues (23-50) (Gilch et al., 2004; Nunziante et al., 2003), following suramin-induced aggregation (Gilch et al., 2004), and with mutant forms of PrPC that are retained in an endoH-insensitive compartment in neurons (Stewart and Harris, 2005). The LRP1-dependent block in transport seen here by lowering LRP1 levels might be a general restriction point in PrPC biosynthesis.

Is LRP1 sufficient for neuronal trafficking of PrPC?

We do not currently have the tools to answer this question definitively, but, from the work described here and ongoing studies, it seems highly likely that LRP1 is the central organiser, but not the sole functional component, of a larger complex that traffics PrPC during biosynthesis and at the cell surface. We find that dissociating LRP1-PrPC complexes is different depending on the cell source (RER microsomes versus cell surface; E.G.M.V., unpublished). Other binding partners might act as co-receptors for cellular PrPC, decreasing its overall affinity for LRP1 sufficiently for RAP (and, presumably, other more physiologically relevant surface ligands such as ApoE) to displace PrPC from the receptor.

Strong candidates for such a role are heparan sulphate proteoglycans (HSPGs). These bind to basic motifs in the N-terminus of PrPC (Warner et al., 2002), affect its rate of endocytosis (Shyng et al., 1995b) and the formation of PrPSc (Ben-Zaken et al., 2003; Deleault et al., 2005). HSPGs have complex interactions with the binding and internalisation of LRP1 ligands such as thrombospondin (Wang et al., 2004) and lipoproteins (Wilsie and Orlando, 2003) and might similarly modulate the association-dissociation kinetics of LRP1-PrPC complexes. We have noted that enzymatic removal of HSPG on sensory neurons decreases the rate of endocytosis of PrPC (Sunyach et al., 2003).

Biological and pathological roles of the LRP1-PrPC interaction on the cell surface

LRP1 performs two roles in internalising proteins: for nutrient uptake (particularly lipid/cholesterol), and, as a surface scavenger, removing spent debris such as protease-inhibitor complexes from the extracellular space (May and Herz, 2003). PrPC could function as part of the LRP1 scavenger receptor complex as its N-terminal domain has multiple binding motifs (Caughey et al., 2006) and its hydrophobic sequence (residues 112-130), which is exposed to the aqueous environment, could bind to denatured proteins as PrPC rapidly traffics across the neuronal surface. A scavenger receptor role is also suggested by the pattern of PrPC expression in vivo, where it is most abundant on cells that might need enhanced levels of protection from the extracellular environment: on neurons, which cannot divide and live as long as the body they control, and on cells that constantly monitor danger in the environment – normal and follicular dendritic cells, intraepithelial lymphocytes and neuroendocrine cells (Ford et al., 2002a; Ford et al., 2002b).

Members of the LRP family could play multiple roles in prion infection. Infectious prion fibrils bind with picomolar affinity to very-low-density lipoproteins (Safar et al., 2006) and so might be cleared from extracellular space by LDL receptors. With neuronal LRP1, the crucial questions are whether LRP1 also binds to infectious prion fibrils and, if so, whether the same molecule of LRP1 (which binds most ligands to both cluster 2 and 4) (May and Herz, 2003) will bind to both the cellular and infectious forms of PrP? Then, given the massive size of LRP1, would such binding of the template and substrate in the prion conversion reaction bring the two together or keep them apart?

A cDNA fragment encoding residues 23-107 of PrPC (Sunyach et al., 2003) with a C-terminal Cys residue (added to provide an anchor for conjugation) was cloned into the pGEX-4T1 vector (GE Healthcare). GST fusion protein was purified on glutathione-sepharose beads in the presence of 1 mM DTT. The Cys residue was blocked with 5 mM iodoacetamide in PBS to prevent disulphide bond formation, confirmed by recovery in non-reducing PAGE of the monomeric fusion protein without higher polymers.

Monomeric affinity-purified Fab against mouse PrP residues 142-162 (referred to as `2S antibody') was coupled to Alexa-Fluor-488 or -594 (Molecular Probes; 1–3 moles of dye per mole of Fab) or to 5 nm gold (British Biocell) as described previously (Sunyach et al., 2003). To detect PrP on immunoblots or for immunocytochemistry of fixed cells, SAF32 and SAF83 (SPI-Bio Massy, France) monoclonal antibodies against PrP were used, directly coupled to fluorochromes or gold for immunocytochemistry. Mouse monoclonals to syntaxin 6 (Abcam) and α-mannosidase II (Covance), the LRP1 ligand α2M* (Research Diagnostics) and cholera toxin B chain (Sigma) were coupled to fluorochromes, as described above. Fe2+-loaded transferrin (Tf) coupled to Alexa-Fluor-488 or Texas Red was from Molecular Probes; both ligands were used at 50 μg/ml.

For detection of LRP1, rabbit antibodies against the entire LRP1 (RRR) (Bu et al., 1995), or its cytoplasmic domain (MMMM) (Zerbinatti et al., 2004), were used; LRP1b was detected with an anti-epitope antibody (Cam et al., 2004). Rabbit antibodies against other neuronal LRP family members (LRP6, LRP8, VLDLR) were from Santa Cruz, and against BiP were from Abcam (ab21685). Rabbit antibodies were detected with our own affinity-purified, species-specific horse anti-rabbit IgG conjugated to Alexa fluorochromes, as described above.

Surface plasmon resonance

To study the binding of GST-PrP23-107 to LRP1 by SPR on a Biacore 3000 (Biacore, Sweden), CM5 sensor chips were activated with a 1:1 mixture of 0.2 M N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide and 0.05 M N-hydroxysuccimide in water. LRP1, purified from human placenta (Moestrup et al., 1993a), was immobilised at a concentration 15 μg/ml in 10 mM sodium acetate pH 3.0, to a receptor density of 20-30 fmol LRP/mm2. Remaining binding sites were blocked with 1 M ethanolamine pH 8.5. A control flow cell was made by performing the activation and blocking procedure only. Samples were dissolved in 10 mM HEPES, 150 mM NaCl, 1.5 mM CaCl2, 1 mM EGTA, pH 7.4 plus 0.005% Tween 20. Sample and running buffers were identical. Samples were injected at a flow rate of 5 μl/minute. Regeneration of the sensor chip after each analysis cycle was performed with 1.6 M glycine-HCl buffer, pH 3.0. The Biacore response is expressed in relative response units (RU), this being the difference in response between the protein and control flow channel. Kinetic parameters were determined by BIAevaluation 4.1 software using a Langmuir 1:1 binding model and simultaneous fitting of all curves in the concentration range.

Sensory neurons and PrPC internalisation

Neurons were used after 3-7 days in culture established from the dorsal root ganglia of 4-8-week-old 129Sv, or Tg20 transgenic (Fischer et al., 1996), mice (Mus musculus) or (for biochemistry) rats (Rattus norvegicus) (Sunyach et al., 2003). Genetically normal rat and mouse neurons endocytosed their endogenous PrPC at the same rate and were inhibited by the siRNALRP1 used with similar efficiency.

For siRNA delivery by penetratin-1 (Davidson et al., 2004; Dom et al., 2003), all extracellular DNA was removed by treating cultures overnight with RNAse-free DNAse (5 units/ml; Qiagen) and including the enzyme in the incubation with siRNA-penetratin.

Endocytosis assays were performed as described previously (Sunyach et al., 2003). Briefly, cells were prelabelled with ligands for 30 minutes at 10-12°C in B-27 supplement-free medium, washed once and transferred to a 37°C incubator for endocytosis, normally for 0-2 minutes. At timed intervals, samples were fixed with 1.5% PFA for 15 minutes, chromatin stained with 4′,6 diamidino-2-phenylindole (DAPI), and mounted in mowiol. Cells were observed with a Zeiss Axiovert 100 microscope with a piezo Z-axis drive on a 63× apochromat 1.4 NA oil objective illuminated with an EXFO X-cite 120 metal-halide lamp and images collected with a Hamamatsu Orca-ER camera. Exposure time (50-500 mseconds) and excitation intensity were set so that points of highest light intensity were within 20-60% saturation for the camera. Images (normally 30) taken every 100 nm through a middle section of the cell body [to obtain multiple data points per wavelength in the Z axis (Heintzmann, 2005)] were transferred to Volocity (Improvision; Warwick, UK), subtractively deconvolved against their seven neighbouring images, assembled into a 3D stack and fluorescence measured using Volocity. Background was set at 10% above the level that resolved the measured fluorescence into multiple discrete objects (rather than record the whole cell as a single fluorescent object). Surface objects were defined by drawing a line just below the surface of each cell.

For EM, gold was labeled with Fab, Tf or α2M* and incubated with cells and processed for EM as described previously (Sunyach et al., 2003). Fields of both PrPC2M* and PrPC-Tf double labeling were viewed to count >500 particles of 5 nm gold labeling for PrPC, and the proximity to them of the 10 nm label for the other two ligands determined. Label for the LRP1 ligand α2M* was present at 80%, and that for Tf at 60%, the abundance of label for PrPC. The relative density of the α2M* and Tf labels was similar (respectively 80% and 60% the density of PrPC label), as was the fraction of label for all three within coated pits (11-18%).

Immunocytochemical labeling

To assess surface immunolabelling, where the relative distribution of surface proteins was crucial (Fig. 2C,D; Table 1), neurons were kept at 37°C as they were washed in PBS and fixed for 15 minutes with 0.5% PFA, then immunolabelled at 4°C. Where the amount rather than surface distribution of surface protein was crucial, living cells were immunolabeled at 10°C, then fixed in 0.5% PFA for 15 minutes. If internal protein was also to be measured, cells were permeabilised at 4°C in Brij-96–PBS for 30 minutes, then internal protein was immunolabelled. Cells were DAPI stained, fixed again in 1.5% PFA-PBS for 1-16 hours before being mounted in mowiol. If primarily internal proteins were to be labeled (e.g. Fig. 6), cells were fixed for 30 minutes with 1.5% PFA at room temperature, then permeabilised for 30 minutes at 4°C in 0.2% Triton-X-100–PBS before immunolabelling. Mowiol moutant was made in PBS containing 1/7 by volume mowiol 4-88, 2/7 glycerol, 0.1% NaN3, 0.1 mg/ml DABCO [1,4 diazabizyclo(2.2.2)octane] and 0.01 mg/ml n-propyl gallate (all from Sigma).

Inhibition of LRP1: RAP and siRNA

Recombinant RAP (80 nM or 1 μM) (Andersen et al., 2001) was preincubated with cells for 30–60 minutes at 37°C before the PrP internalisation assay was performed. The siRNALRP1.1 sequence was adapted for the mouse from the human sequence that we have found to be effective in suppressing LRP1 in human smooth muscle cells (Li et al., 2003); sense strand Th-5′-GCAGUUUGCCUGCAGAGAGdTdT-3′, antisense strand 5′UCUCGCAGGCAAACUGCdTdT-3′). The control siRNACon corresponded to the reverse of the siRNALRP1 sequence. NCBI Blastn showed that the siRNALRP1.1 would only target mRNA encoding Lrp1 and that there would be no target for siRNACon. In addition, siRNALRP1.2 (sense strand Th-5′-CGUUGGUUAUGCACAUGAAdTdT-3′, antisense strand 5′UUCAUGUGCAUAACCAACGdTdT-3′), and siRNALRP1.3 (sense strand Th-5′-GCCGGGUGUACAAAUGUAAdTdT-3′, antisense strand 5′UUACAUUUGUACACCCGGCdTdT-3′) were predesigned and homology tested using proprietary algorithms by the manufacturer (Qiagen). The appropriate thio-modified double-stranded RNAs (Dharmacon and Qiagen) were coupled to penetratin-1 (Quantum Biotechnologies) following Davidson and colleagues (Davidson et al., 2004) and added to cells at a final concentration of 250 nM.

Immunoprecipitation

For sequential immunoprecipitation of surface then intracellular antigen, antibody [SAF32 (1 μg) for PrPC; RRR (3 μg) for LRP1; Ox7 (1 μg) for Thy-1] was added to 1.5 ml of culture medium and neurons held at 10°C for 30 minutes with gentle rocking before being washed twice in ice-cold PBS and recovered from the plate by aspiration. Cells were lysed in 0.5% Brij 96 plus 0.5% sodium deoxycholate plus 1 μM BSA. Nuclei were pelleted at 2400 g for 5 minutes, and protein A Dynal beads (10% v/v) were incubated with the supernatant for 30 minutes at 4°C, then washed with lysis buffer, and antigen eluted using Laemmli SDS-PAGE sample buffer.

Internal antigen was then immunoprecipitated by incubating the unbound fraction with primary antibodies followed by protein A Dynal beads and eluted with 0.1% SDS in 10 mM Tris pH 6.8 for digestion with endoglycosidase H (endoH).

For hydrolysis of core glycan chains with endoH, samples were reduced with 10 mM DTT for 5 minutes at 100°C, diluted twofold in 0.5 M citrate buffer pH 5.5 plus 0.1 mM EDTA and endoH (Roche) added at 0.1 U/ml for 60 minutes at 37°C. The reaction was stopped by boiling samples in Laemmli sample buffer.

We thank Carol Troy (Columbia, NY) for advice on coupling and use of penetratin-siRNA, Charles Weissmann for the Tg20 mice, Ken Brady (Centre for Ultrastructural Imaging, King's College London, UK) for expert assistance with the EM, and Maria Woolston for positive controls for antibodies against the LRP family; we also thank Helen Cox, Paul Felts and Susan Standring for many useful discussions, and Improvision for continuing support. This work was supported by BBSRC grants 18/BS516350 and BB/C506680/1. We also acknowledge the reviewers for their incisive, constructive comments that have much improved this paper. This work was supported by BBSRC grants 18/BS516350 and BB/C506680/1, and an MRC doctoral training studentship to C.J.P.

Andersen, O. M., Schwarz, F. P., Eisenstein, E., Jacobsen, C., Moestrup, S. K., Etzerodt, M. and Thogersen, H. C. (
2001
). Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP.
Biochemistry
40
,
15408
-15417.
Ben-Zaken, O., Tzaban, S., Tal, Y., Horonchik, L., Esko, J. D., Vlodavsky, I. and Taraboulos, A. (
2003
). Cellular heparan sulfate participates in the metabolism of prions.
J. Biol. Chem.
278
,
40041
-40049.
Brügger, B., Graham, C. H., Leibrecht, I., Mombelli, E., Jen, A., Wieland, F. T. and Morris, R. J. (
2004
). The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition.
J. Biol. Chem.
279
,
7530
-7536.
Bruses, J. L. (
2006
). N-cadherin signaling in synapse formation and neuronal physiology.
Mol. Neurobiol.
33
,
237
-252.
Bu, G. and Rennke, S. (
1996
). Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein.
J. Biol. Chem.
271
,
22218
-22224.
Bu, G., Maksymovitch, E. A., Nerbonne, J. M. and Schwartz, A. L. (
1994
). Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons.
J. Biol. Chem.
269
,
18521
-18528.
Bu, G., Geuze, H. J., Strous, G. J. and Schwartz, A. L. (
1995
). 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein.
EMBO J.
14
,
2269
-2280.
Bu, G., Rennke, S. and Geuze, H. J. (
1997
). ERD2 proteins mediate ER retention of the HNEL signal of LRP's receptor-associated protein (RAP).
J. Cell Sci.
110
,
65
-73.
Cam, J. A., Zerbinatti, C. V., Knisely, J. M., Hecimovic, S., Li, Y. and Bu, G. (
2004
). The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production.
J. Biol. Chem.
279
,
29639
-29646.
Caughey, B., Caughey, W. S., Kocisko, D. A., Lee, K. S., Silveira, J. R. and Morrey, J. D. (
2006
). Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: a common mechanism for anti-TSE compounds?
Acc. Chem. Res.
39
,
646
-653.
Davidson, T. J., Harel, S., Arboleda, V. A., Prunell, G. F., Shelanski, M. L., Greene, L. A. and Troy, C. M. (
2004
). Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation.
J. Neurosci.
24
,
10040
-10046.
Deleault, N. R., Geoghegan, J. C., Nishina, K., Kascsak, R., Williamson, R. A. and Supattapone, S. (
2005
). Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.
J. Biol. Chem.
280
,
26873
-26879.
Dom, G., Shaw-Jackson, C., Matis, C., Bouffioux, O., Picard, J. J., Prochiantz, A., Mingeot-Leclercq, M. P., Brasseur, R. and Rezsohazy, R. (
2003
). Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation.
Nucleic Acids Res.
31
,
556
-561.
Fischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A. and Weissmann, C. (
1996
). Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.
EMBO J.
15
,
1255
-1264.
Fisher, C., Beglova, N. and Blacklow, S. C. (
2006
). Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors.
Mol. Cell
22
,
277
-283.
Ford, M. L., Burton, L. J., Li, H., Graham, C. H., Frobert, Y., Grassi, J., Hall, S. M. and Morris, R. J. (
2002a
). A marked disparity between the expression of prion protein and its message by neurons of the central nervous system.
Neuroscience
111
,
533
-551.
Ford, M. L., Burton, L. J., Morris, R. J. and Hall, S. M. (
2002b
). Selective expression of prion protein in peripheral tissues of the adult mouse.
Neuroscience
113
,
177
-192.
Gauczynski, S., Peyrin, J. M., Haik, S., Leucht, C., Hundt, C., Rieger, R., Krasemann, S., Deslys, J. P., Dormont, D., Lasmezas, C. I. et al. (
2001
). The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein.
EMBO J.
20
,
5863
-5875.
Gilch, S., Nunziante, M., Ertmer, A., Wopfner, F., Laszlo, L. and Schatzl, H. M. (
2004
). Recognition of lumenal prion protein aggregates by post-ER quality control mechanisms is mediated by the preoctarepeat region of PrP.
Traffic
5
,
300
-313.
Heintzmann, R. (
2005
). Band limit and appropriate sampling in microscopy. In
Cell Biology: A Laboratory Handbook
(ed. K. Simons, J. V. Small, T. Hunter, D. Shotton, J. E. Celis and N. Carter), pp.
29
-36. Amsterdam: Elsevier.
Herz, J. and Chen, Y. (
2006
). Reelin, lipoprotein receptors and synaptic plasticity.
Nat. Rev. Neurosci.
7
,
850
-859.
Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H. and Stanley, K. K. (
1988
). Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.
EMBO J.
7
,
4119
-4127.
Horn, I. R., van den Berg, B. M., Moestrup, S. K., Pannekoek, H. and van Zonneveld, A. J. (
1998
). Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Thromb. Haemost.
80
,
822
-828.
Hornemann, S., Schorn, C. and Wuthrich, K. (
2004
). NMR structure of the bovine prion protein isolated from healthy calf brains.
EMBO Rep.
5
,
1159
-1164.
Iadonato, S. P., Bu, G., Maksymovitch, E. A. and Schwartz, A. L. (
1993
). Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
Biochem. J.
296
,
867
-875.
Kazmin, D. A., Chinenov, Y., Larson, E. and Starkey, J. R. (
2003
). Comparative modeling of the N-terminal domain of the 67kDa laminin-binding protein: implications for putative ribosomal function.
Biochem. Biophys. Res. Commun.
300
,
161
-166.
Kusumi, A., Nakada, C., Ritchie, K., Murase, K., Suzuki, K., Murakoshi, H., Kasai, R. S., Kondo, J. and Fujiwara, T. (
2005
). Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules.
Annu. Rev. Biophys. Biomol. Struct.
34
,
351
-378.
Lee, D., Walsh, J. D., Mikhailenko, I., Yu, P., Migliorini, M., Wu, Y., Krueger, S., Curtis, J. E., Harris, B., Lockett, S. et al. (
2006
). RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi.
Mol. Cell
22
,
423
-430.
Li, Y., Marzolo, M. P., van Kerkhof, P., Strous, G. J. and Bu, G. (
2000
). The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein.
J. Biol. Chem.
275
,
17187
-17194.
Li, Y., Lu, W. and Bu, G. (
2003
). Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration.
FEBS Lett.
555
,
346
-350.
Linden, R., Martins, V. R., Prado, M. A., Izquierdo, I. and Brentani, R. R. (
2008
). Physiology of the prion protein.
Physiol. Rev.
In press.
Madore, N., Smith, K. L., Graham, C. H., Jen, A., Brady, K., Hall, S. and Morris, R. (
1999
). Functionally different GPI proteins are organised in different domains on the neuronal surface.
EMBO J.
18
,
6917
-6926.
Mange, A., Milhavet, O., Umlauf, D., Harris, D. and Lehmann, S. (
2002
). PrP-dependent cell adhesion in N2a neuroblastoma cells.
FEBS Lett.
514
,
159
-162.
Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A. and Pfrieger, F. W. (
2001
). CNS synaptogenesis promoted by glia-derived cholesterol.
Science
294
,
1354
-1357.
May, P. and Herz, J. (
2003
). LDL receptor-related proteins in neurodevelopment.
Traffic
4
,
291
-301.
May, P., Rohlmann, A., Bock, H. H., Zurhove, K., Marth, J. D., Schomburg, E. D., Noebels, J. L., Beffert, U., Sweatt, J. D., Weeber, E. J. et al. (
2004
). Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.
Mol. Cell. Biol.
24
,
8872
-8883.
Melman, L., Geuze, H. J., Li, Y., McCormick, L. M., Van Kerkhof, P., Strous, G. J., Schwartz, A. L. and Bu, G. (
2002
). Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.
Mol. Biol. Cell
13
,
3325
-3335.
Moestrup, S. K., Gliemann, J. and Pallesen, G. (
1992
). Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues.
Cell Tissue Res.
269
,
375
-382.
Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thogersen, H. C., Nykjaer, A., Andreasen, P. A., Rasmussen, H. H., Sottrup-Jensen, L. and Gliemann, J. (
1993a
). Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats.
J. Biol. Chem.
268
,
13691
-13696.
Moestrup, S. K., Nielsen, S., Andreasen, P., Jorgensen, K. E., Nykjaer, A., Roigaard, H., Gliemann, J. and Christensen, E. I. (
1993b
). Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.
J. Biol. Chem.
268
,
16564
-16570.
Moestrup, S. K., Schousboe, I., Jacobsen, C., Leheste, J. R., Christensen, E. I. and Willnow, T. E. (
1998
). beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.
J. Clin. Invest.
102
,
902
-909.
Morris, R. J., Parkyn, C. J. and Jen, A. (
2006
). Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease.
FEBS Lett.
580
,
5565
-5571.
Nunziante, M., Gilch, S. and Schatzl, H. M. (
2003
). Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein.
J. Biol. Chem.
278
,
3726
-3734.
Nykjaer, A., Fyfe, J. C., Kozyraki, R., Leheste, J. R., Jacobsen, C., Nielsen, M. S., Verroust, P. J., Aminoff, M., de la Chapelle, A., Moestrup, S. K. et al. (
2001
). Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3).
Proc. Natl. Acad. Sci. USA
98
,
13895
-13900.
Peters, P. J., Mironov, A., Jr, Peretz, D., van Donselaar, E., Leclerc, E., Erpel, S., DeArmond, S. J., Burton, D. R., Williamson, R. A., Vey, M. et al. (
2003
). Trafficking of prion proteins through a caveolae-mediated endosomal pathway.
J. Cell Biol.
162
,
703
-717.
Pietrzik, C. U., Yoon, I. S., Jaeger, S., Busse, T., Weggen, S. and Koo, E. H. (
2004
). FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein.
J. Neurosci.
24
,
4259
-4265.
Safar, J. G., Wille, H., Geschwind, M. D., Deering, C., Latawiec, D., Serban, A., King, D. J., Legname, G., Weisgraber, K. H., Mahley, R. W. et al. (
2006
). Human prions and plasma lipoproteins.
Proc. Natl. Acad. Sci. USA
103
,
11312
-11317.
Salicioni, A. M., Gaultier, A., Brownlee, C., Cheezum, M. K. and Gonias, S. L. (
2004
). Low density lipoprotein receptor-related protein-1 promotes beta1 integrin maturation and transport to the cell surface.
J. Biol. Chem.
279
,
10005
-10012.
Scott, B. S. (
1977
). Adult mouse dorsal root ganglia neurons in cell culture.
J. Neurobiol.
8
,
417
-427.
Shmerling, D., Hegyi, I., Fischer, M., Blattler, T., Brandner, S., Gotz, J., Rulicke, T., Flechsig, E., Cozzio, A., von Mering, C. et al. (
1998
). Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.
Cell
93
,
203
-214.
Shyng, S.-L., Heuser, J. E. and Harris, D. A. (
1994
). A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits.
J. Cell Biol.
125
,
1239
-1250.
Shyng, S.-L., Moulder, K. L., Lesko, A. and Harris, D. A. (
1995a
). The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits.
J. Biol. Chem.
270
,
14793
-14800.
Shyng, S. L., Lehmann, S., Moulder, K. L. and Harris, D. A. (
1995b
). Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.
J. Biol. Chem.
270
,
30221
-30229.
Springer, T. A. (
1998
). An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components.
J. Mol. Biol.
283
,
837
-862.
Stewart, R. S. and Harris, D. A. (
2005
). A transmembrane form of the prion protein is localized in the Golgi apparatus of neurons.
J. Biol. Chem.
280
,
15855
-15864.
Sunyach, C., Jen, A., Deng, J., Fitzgerald, K., Frobert, Y., McCaffrey, M. and Morris, R. J. (
2003
). The mechanism of internalisation of GPI anchored prion protein.
EMBO J.
22
,
3591
-3601.
Taylor, D. R. and Hooper, N. M. (
2007
). The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein.
Biochem. J.
402
,
17
-23.
Wang, S., Herndon, M. E., Ranganathan, S., Godyna, S., Lawler, J., Argraves, W. S. and Liau, G. (
2004
). Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.
J. Cell. Biochem.
91
,
766
-776.
Warner, R. G., Hundt, C., Weiss, S. and Turnbull, J. E. (
2002
). Identification of the heparan sulphate binding sites in the cellular prion protein.
J. Biol. Chem.
277
,
18421
-18430.
Willnow, T. E., Rohlmann, A., Horton, J., Otani, H., Braun, J. R., Hammer, R. E. and Herz, J. (
1996
). RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors.
EMBO J.
15
,
2632
-2639.
Wilsie, L. C. and Orlando, R. A. (
2003
). The low density lipoprotein receptor-related protein complexes with cell surface heparan sulfate proteoglycans to regulate proteoglycan-mediated lipoprotein catabolism.
J. Biol. Chem.
278
,
15758
-15764.
Wu, L. and Gonias, S. L. (
2005
). The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts.
J. Cell. Biochem.
96
,
1021
-1033.
Zerbinatti, C. V., Wozniak, D. F., Cirrito, J., Cam, J. A., Osaka, H., Bales, K. R., Zhuo, M., Paul, S. M., Holtzman, D. M. and Bu, G. (
2004
). Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein.
Proc. Natl. Acad. Sci. USA
101
,
1075
-1080.
Zuber, B., Nikonenko, I., Klauser, P., Muller, D. and Dubochet, J. (
2005
). The mammalian central nervous synaptic cleft contains a high density of periodically organized complexes.
Proc. Natl. Acad. Sci. USA
102
,
19192
-19197.

Supplementary information